0,1
6.4.8 Guidelines for the first-line treatment of hormone-sensitive metastatic disease*,
Recommendations,Strength rating
"At the start of ADT offer luteinising hormone-releasing hormone (LHRH) antagonists 
or orchiectomy to patients with impending clinical complications like spinal cord 
compression or bladder outlet obstruction.",Strong
"Offer docetaxel only in combination with ADT plus abiraterone or darolutamide to 
patients with M1 disease and who are fit for docetaxel.",Strong
"Offer ADT combined with non-curative prostate radiotherapy (using doses up to 
the equivalent of 72 Gy in 2 Gy fractions) to patients whose first presentation is M1 
disease and who have low volume of disease by CHAARTED criteria/M1a disease.",Strong
